1. Guest, the 'News in Brief' for the week beginning 11th January 2021 is here.
    Dismiss Notice
  2. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Interview with ME researcher Jonas Bergquist Nov 2020

Discussion in 'BioMedical ME/CFS News' started by Sly Saint, Nov 17, 2020.

  1. Sly Saint

    Sly Saint Senior Member (Voting Rights)

    Likes Received:
    ahimsa, Barry, MEMarge and 17 others like this.
  2. Helene

    Helene Established Member (Voting Rights)

    Likes Received:
    Just listened. Interesting, good update on his current research and his thoughts on other ME developments, and calm easy to listen to this kind, knowledgable and dedicated researcher.
    Trish, Anna H, MEMarge and 9 others like this.
  3. Perrier

    Perrier Senior Member (Voting Rights)

    Likes Received:
    Gosh, I hope I fall asleep tonight--that's how agitated I became after the interview--even though he was calm, rational, insightful, level headed and a from what I heard, a good scientist. But basically, Dr Bergquist summarised what most of us already have learned from the various summaries on the current research. So, he really did not add anything new here at all. The thing that struck me most was that he kept saying and repeating in one way or another: = we need to study that further, we need to look at that, that needs validation, there is limited funding...those were the phrases that bubbled up to the surface over and over again. He is a very intelligent man, who diplomatically knew how to dismiss bunkum ideas, and I appreciated that very much. But after listening to this interview, and from his phrasing he sees a very very long road ahead in terms of the research that still needs to be done for ME.

    The question for me then is: will it be decades before there are some answers?
    (Please note that he said it was only in 2019 that he finally came on board with OMF and then he organised a tiny group to work on ME in his home country!) And the subject of possible and readily available treatments was therefore not even really part of this interview.
    Snow Leopard, jaded, sebaaa and 7 others like this.
  4. leokitten

    leokitten Senior Member (Voting Rights)

    Likes Received:
    Most ME researchers have this same type of interview... way more ideas than money, very little true progress year after year due to lack of funding, etc. Even if he had funding, research is painfully slow and remember he is only one single lab.

    When I see interviews of well funded researchers in other diseases when they give updates from the year or two before it’s typically not a big leap at all once you filter through the excitement and optimistic hyperbole lab heads typically exhibit. When the dust settles it’s just very incremental progress.

    The way things happen somewhat faster is when there are like 30+ very well funded labs in a hyper-competitive environment racing to beat each other. Not like what see with ME currently.

    So to be blunt but realistic, it is much more likely that it will take many years to decades before we have some actionable answers and potential treatments.

    The only way this could be shortcut, which is low probability, is by almost happy accident finding some already FDA approved drug that works or e.g. there is some miracle shortcut like long COVID research answering something that applies to us. But via the slow march of basic research happening currently in ME world this is going to take forever.

    Im in my mid 40s and have come terms that there will probably not be an effective treatment that comes before I’m already old. ME already makes me feel everyday like I’m 90 years old so what difference will it make then.
    Last edited: Nov 22, 2020
  5. Milo

    Milo Senior Member (Voting Rights)

    Likes Received:
    I attended a presentation last year at a university, and the researcher lamented that with 50 millions funding for dementia, they could’t do much.

    To me it reflects on the additional barriers we are facing in the field of ME, the paucity of researchers, the stigma, the lack of funding. Maybe COVID (and the fact that many will not recover) will change that.
    Last edited: Nov 23, 2020

Share This Page